North America IUCD Devices Market

Date: October 1, 2017
Pages: 150
Price:
US$ 2,500.00 US$ 2,250.00
Offer valid until January 31, 2019!
License [?]:
Publisher: Data Bridge Market Research
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: N871AADABC3EN
Leaflet:

Download PDF Leaflet

In this region, North America IUCD devices market is projected to reach USD 1,441.0 million by 2024, from USD 872.3 million in 2016 growing at a CAGR of 6.6% in the forecast period 2017 to 2024.

Based on geography, the North America IUCD devices market is segmented into 3 geographical regions, such as,
  • U.S.,
  • Mexico,
  • Canada
North America IUCD devices market competition by top players including

Bayer AG dominated the IUCD devices market, followed by Teva Pharmaceuticals Industries Ltd., and Mona Lisa N.V. Also Medigen Distribution, Inc. and Allergen PLC are expected to hold respectively. Some of the other players in this market include
  • DKT International,
  • Egemen International,
  • Melbea AG,
  • Ocon Medical Ltd.,
  • Pregna International Limited,
  • Medical Engineering Corporation SA
  • SMB Corporation
  • Meril Life Sciences Pvt. Ltd.,
  • Medu Scientific Ltd,
  • China RH Contraceptives Co., Ltd,
  • Sanghai Jolly Medical Education Co., Ltd,
  • Bernstein Leibhard LLP,
  • Zheijang Daji Medical Instruments, Ltd.,
  • Nimble International,
  • AME Line,
  • Technico,
  • Cepeo,
  • Contraceptivos,
  • Injeflex Ind And Com Ltda,
  • Bersil, Amed
The North America intra-uterine contraceptive devices market is segmented on the basis of product type, end user, and geography.

The North America intra-uterine contraceptive devices market is segmented into 2 product types, namely copper IUCD and hormonal IUCD.

On the basis of end users the market is segmented into hospitals, gynaecology clinics, and community healthcare.
1. INTRODUCTION

1.1. OVERVIEW OF NORTH AMERICA INTRA-UTERINE CONTRACEPTIVE DEVICES (IUCD) MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED

2. MARKET SEGMENTATION

2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS

3. MARKET OVERVIEW

3.1. DRIVERS
  3.1.1. INCREASED RATE OF UNPLANNED PREGNANCIES
  3.1.2. RISING NUMBER OF INITIATIVES UNDERTAKEN BY THE PRIVATE FIRMS
  3.1.3. FAVOURABLE INSURANCE FOR IUCD’S
  3.1.4. GROWING AWARENESS OF CONTRACEPTIVE
  3.1.5. GROWING FUNDS AND GRANTS FOR IUCD PRODUCTS
  3.1.6. TECHNOLOGICAL ADVANCEMENTS
3.2. RESTRAINTS
  3.2.1. HIGH COST OF TREATMENT
  3.2.2. THREAT OF CAUSING PELVIC INFLAMMOTORY DISEASE (PID)
  3.2.3. THREAT CAUSING EPICTAPIC PREGNANCY
  3.2.4. CHANGES IN GOVERNMENT REGULATIONS

4. EXECUTIVE SUMMARY

5. PREMIUM INSIGHTS

6. NORTH AMERICA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, BY PRODUCT TYPE

6.1. OVERVIEW

7. NORTH AMERICA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, BY GEOGRAPHY

7.1. OVERVIEW
7.2. NORTH AMERICA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
  7.2.1. U.S. INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
  7.2.2. CANADA INTRA-UTERINE CONTRACEPTIVE
(IUCD) DEVICES MARKET
  7.2.3. MEXICO INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

8. NORTH AMERICA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, COMPANY SHARE

8.1. COMPANY SHARE ANALYSIS: NORTH AMERICA
8.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
8.3. COMPANY SHARE ANALYSIS: EUROPE
8.4. COMPANY SHARE ANALYSIS: ASIA PACIFIC
8.5. COMPANY SHARE ANALYSIS: SOUTH AMERICA
8.6. COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA

9. COMPANY PROFILES

9.1. BAYER AG
  9.1.1. COMPANY OVERVIEW
  9.1.2. SWOT (STRENGTH, WEAKNESS, OPPORTUNITIES AND THREATS)
  9.1.3. REVENUE ANALYSIS
  9.1.4. PRODUCT PORTFOLIO
  9.1.5. RECENT DEVELOPMENTS
  9.1.6. DATA BRIDGE ANALYSIS
9.2. TEVA PHARMACEUTICAL INDUSTRIES LTD.
  9.2.1. COMPANY OVERVIEW
  9.2.2. REVENUE ANALYSIS
  9.2.3. SWOT (STRENGTH, WEAKNESS, OPPORTUNITIES AND THREATS)
  9.2.4. PRODUCT PORTFOLIO
  9.2.5. RECENT DEVELOPMENTS
  9.2.6. DATA BRIDGE ANALYSIS
9.3. ALLERGEN PLC
  9.3.1. COMPANY OVERVIEW
  9.3.2. REVENUE ANALYSIS
  9.3.3. PRODUCT PORTFOLIO
  9.3.4. RECENT DEVELOPMENTS
  9.3.5. DATA BRIDGE ANALYSIS
9.4. DKT INTERNATIONAL
  9.4.1. COMPANY OVERVIEW
  9.4.2. REVENUE ANALYSIS
  9.4.3. PRODUCT PORTFOLIO
9.5. SMB CORPORATION
  9.5.1. COMPANY OVERVIEW
  9.5.2. REVENUE ANALYSIS
  9.5.3. PRODUCT PORTFOLIO
  9.5.4. RECENT DEVELOPMENTS
  9.5.5. DATA BRIDGE ANALYSIS
9.6. OCON MEDICAL LTD.
  9.6.1. COMPANY OVERVIEW
  9.6.2. REVENUE ANALYSIS
  9.6.3. PRODUCT PORTFOLIO
  9.6.4. RECENT DEVELOPMENTS
  9.6.5. DATA BRIDGE ANALYSIS
9.7. MONA LISA N.V.
  9.7.1. COMPANY OVERVIEW
  9.7.2. REVENUE ANALYSIS
  9.7.3. PRODUCT PORTFOLIO
  9.7.4. RECENT DEVELOPMENTS
9.8. MEDISAFE DISTRIBUTION INC.
  9.8.1. COMPANY OVERVIEW
  9.8.2. REVENUE ANALYSIS
  9.8.3. PRODUCT PORTFOLIO
  9.8.4. RECENT DEVELOPMENTS

10. RELATED REPORTS

TABLE LIST

TABLE 1 NORTH AMERICA IUCD DEVICES MARKET, BY COUNTRY, 2013 – 2024 (USD MILLION)
TABLE 2 NORTH AMERICA IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (USD MILLION)
TABLE 3 NORTH AMERICA IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (UNITS)
TABLE 4 NORTH AMERICA IUCD DEVICES MARKET, BY END USER, 2013 – 2024 (USD MILLION)
TABLE 5 U.S. IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (USD MILLION)
TABLE 6 U.S. IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (UNITS)
TABLE 7 U.S. IUCD DEVICES MARKET, BY END USER, 2013 – 2024 (USD MILLION)
TABLE 8 CANADA IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (USD MILLION)
TABLE 9 CANADA IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (UNITS)
TABLE 10 CANADA IUCD DEVICES MARKET, BY END USER, 2013 – 2024 (USD MILLION)
TABLE 11 MEXICO IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (USD MILLION)
TABLE 12 MEXICO IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (UNITS)
TABLE 13 MEXICO IUCD DEVICES MARKET, BY END USER, 2013 – 2024 (USD MILLION)

FIGURES LIST

FIGURE 1 NORTH AMERICA IS EXPECTED TO BE THE HIGHEST GROWING MARKET FOR INTRA-UTERINE CONTRACEPTIVE DEVICES IN 2016 AND IS EXPECTED TO CONTINUE THIS TREND IN THE FORECAST PERIOD TO 2024
FIGURE 2 NORTH AMERICA IS THE HIGHEST GROWING AND MOST PROFITABLE REVENUE POCKETS FOR INTRA-UTERINE CONTRACEPTIVE DEVICES (IUCD) MANUFACTURERS IN THE FORECAST PERIOD 2017 TO 2024
FIGURE 3 NORTH AMERICA IUCD DEVICES MARKET: BY COUNTRY, SNAPSHOT 2016 & 2024
FIGURE 4 NORTH AMERICA IUCD MARKET: COMPANY SHARE 2016 (%)

COMPNIES PROFILES

DKT International, Egemen International, Melbea AG, Ocon Medical Ltd., Pregna International Limited, Medical Engineering Corporation SA SMB Corporation Meril Life Sciences Pvt. Ltd., Medu Scientific Ltd, China RH Contraceptives Co., Ltd, Sanghai Jolly Medical Education Co., Ltd, Bernstein Leibhard LLP, Zheijang Daji Medical Instruments, Ltd., Nimble International, AME Line, Technico, Cepeo
Skip to top


North America Orthotic Devices Market Outlook to 2025 US$ 5,995.00 Aug, 2018 · 75 pages
North America Respiratory Devices Market Outlook to 2025 US$ 5,995.00 Oct, 2018 · 225 pages
North America Ultrasound Devices Market (2016-2022) US$ 1,500.00 Oct, 2016 · 105 pages
North America Hybrid Devices Market (2016 - 2022) US$ 1,500.00 Nov, 2016 · 72 pages

Ask Your Question

North America IUCD Devices Market
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: